Hydrosoluble fiber (Plantago ovata husk) and levodopa II: experimental study of the pharmacokinetic interaction in the presence of carbidopa.
Levodopa combined with carbidopa constitutes one of the most frequent medication in the treatment of Parkinson's disease. Plantago ovata husk (water-soluble fiber) improves levodopa absorption conditions, but when this drug is administered with carbidopa, fiber could reduce its effectiveness. The purpose of this study is to investigate whether the presence of P. ovata husk modifies in rabbits the bioavailability and other pharmacokinetic parameters of levodopa (20 mg/kg) when administered by the oral route with carbidopa (5 mg/kg). We have also studied whether pharmacokinetic modifications are fiber-dose dependent (100 and 400 mg/kg). When levodopa and carbidopa were administered with 100 mg/kg P. ovata husk, the value of AUC for levodopa diminishes 29.7% (sign, n=6, P<0.05) and Cmax 28.1% (sign, n=6, P<0.05) in relation to the values obtained when these drugs were administered without fiber. If the dose of fiber was 400 mg/kg, the decrease was smaller: 20.4% for AUC (no significant difference) and 24.6% for Cmax (sign, n=6, P<0.05), that may indicate an inhibitory action of AADC by the fiber or any of its partial hydrolysis products. On the other hand, since certain time on, levodopa concentrations are always higher in the groups that receive fiber: 210 min with 100 mg/kg and 150 min with 400 mg/kg. The administration of P. ovata husk with levodopa/carbidopa to patients with Parkinson disease could be beneficial and in particular in those patients who also suffer constipation due to an improvement of levodopa kinetic profile with higher final concentrations, a longer plasma half-life and lower Cmax.
Fernandez
Nelida
N
Area de Farmacologia, Universidad de Leon, 24071 Leon, Spain. dftnfm@unileon.es
Carriedo
Demetrio
D
Sierra
Matilde
M
Diez
M Jose
MJ
Sahagun
Ana
A
Calle
Angela
A
Gonzalez
Aranzazu
A
Garcia
Juan J
JJ
D000284:Administration, Oral; D000818:Animals; D019540:Area Under Curve; D002230:Carbidopa / Q000494:pharmacology*; D004043:Dietary Fiber / Q000008:administration & dosage / Q000494:pharmacology*; D007980:Levodopa / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology*; D008657:Metabolic Clearance Rate; D023421:Models, Animal; D008954:Models, Biological; D008517:Phytotherapy; D010943:Plantago; D011817:Rabbits
D004043:Dietary Fiber; D007980:Levodopa; D002230:Carbidopa